NuCana
City of Edinburgh, Scotland, United Kingdom · Biotechnology, Health Care, Medical
NuCana is a clinical-stage biopharmaceutical company developing safer and more effective cancer treatments by applying its proprietary ProTide technology to transform widely used chemotherapy agents. With a pipeline that includes NUC-7738 and NUC-3373, NuCana aims to overcome the limitations of conventional nucleoside analogs and improve outcomes for patients with solid and hematological tumors.
Key facts
- Headquarters
- City of Edinburgh, Scotland, United Kingdom
- Employees
- 23
- Industries
- Biotechnology, Health Care, Medical
- Status
- Public (NCNA)
- Website
- nucanabiomed.com
- Company page
Recent activity at NuCana
- : NuCana Appoints Theresa Bruce as Chief Operating Officer
- : NuCana plc announces initial data from the Phase 1b/2 study of NUC-3373 for advanced solid tumors treatment.
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
Leadership
- Jeffrey Bloss, Chief Medical Officer
- Theresa Bruce, Chief Operating Officer
Verified email and direct lines for NuCana’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.
Companies similar to NuCana
- Citius Oncology · Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics
- Ellipses Pharma Limited · Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics
- ESSA Pharma · Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics
- Amplio Pharma · Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics
- Lipella Pharmaceuticals · Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics
About NuCana: questions and answers
What does NuCana do?
NuCana is a clinical-stage biopharmaceutical company developing safer and more effective cancer treatments by applying its proprietary ProTide technology to transform widely used chemotherapy agents. With a pipeline that includes NUC-7738 and NUC-3373, NuCana aims to overcome the limitations of conventional nucleoside analogs and improve outcomes for patients with solid and hematological tumors.
Where is NuCana headquartered?
NuCana is headquartered in City of Edinburgh, Scotland, United Kingdom.
How many employees does NuCana have?
NuCana has about 23 employees.
What is the latest news on NuCana?
On Jan 6, 2026, NuCana Appoints Theresa Bruce as Chief Operating Officer
Is NuCana a public company?
Yes. NuCana is publicly traded under the ticker NCNA.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy